Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline
Jetske van der Schaar(Amsterdam Neuroscience), Eva C. A. Asscher(Amsterdam University Medical Centers), Mardou S. S. A. van Leeuwenstijn‐Koopman(Amsterdam Neuroscience), Mariëtte A. van den Hoven(Amsterdam University Medical Centers), Leonie N. C. Visser(University Medical Center Utrecht), S. A. M. Sikkes(Amsterdam Neuroscience), A. L. Bredenoord(Erasmus University Rotterdam), Wiesje M. van der Flier(Amsterdam Neuroscience), Elsmarieke van de Giessen(Amsterdam Neuroscience), Calvin Trieu(Amsterdam Neuroscience), Argonde C. van Harten(Amsterdam Neuroscience), Heleen M.A. Hendriksen(MACOM (United States))
Cited by 0
Related Papers
Addressing the risk of maladaptation to climate change
|Wiley Interdisciplinary Reviews Climate Change|2016|430
Gut Microbiota Composition Is Related to AD Pathology
|Frontiers in Immunology|2022|222
Herpes zoster after COVID vaccination
|International Journal of Infectious Diseases|2021|95
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
|Alzheimer s Research & Therapy|2022|66
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6
|Alzheimer s Research & Therapy|2021|61